Valneva SE (VLA.VI)
| Previous Close | 5.77 |
| Open | 5.34 |
| Bid | 5.02 x 50000 |
| Ask | 5.09 x 81200 |
| Day's Range | 5.06 - 5.35 |
| 52 Week Range | 2.06 - 5.35 |
| Volume | |
| Avg. Volume | 14,123 |
| Market Cap | 455.476M |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.71 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of American Depositary Shares and Ordinary Shares
Saint Herblain (France), September 28, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”), a specialty vaccine company, today announced its intention to issue and sell, subject to market conditions, approximately $40 million of its ordinary shares in a global offering to specified categories of investors comprised of (i) a public offering of its American Depositary Shares (“ADSs”), each representing two ordinary shares, in the United States (the “U.S. Offering”) and (ii) a con
- Zacks
Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why
Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.
- Reuters
UPDATE 2-Valneva in talks with potential partner on second-gen COVID-19 vaccines
French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets new variants of the disease, sending its shares up. Valneva has won regulatory approval in the European Union and some other countries for its first-generation vaccine, but said it has suspended manufacturing in light of low order levels. "Market expectations have been that the company would be winding down its COVID-19 vaccine activities, hence the bounce...", said Rx Securities Managing Director Samir Devani, adding that he advised investors to consider any COVID-19 activities as an upside option for the stock.
